Kidmin Special Precautions

Careful administration (KIDMIN should be administered with care in the following patients): Patients with cardiovascular dysfunction. (An increase in the circulating blood volume may worsen the patient's clinical condition).
Patients with hepatic disorder or gastrointestinal bleeding. (Excess accumulation of amino acids or hyperammonemia may be induced).
Patients with severe electrolyte imbalance or abnormal acid-base balance. (The patient's clinical condition may be worsened).
Patients with severe acidosis. (The patient's clinical condition may be worsened).
Important precautions: This product should be used in patients who need parenteral nutrition because oral or enteral nutrition is inadequate or not possible.
Use in Children: The safety of KIDMIN in children has not been established (insufficient clinical experience).
Physiological systems for the metabolism of various amino acids may not be fully developed in children. It is therefore advisable to take special precautions such as reducing the infusion rate when administering KIDMIN to pediatric patients.
KIDMIN may induce hyperkalemia in low birth weight infants. If hyperkalemia develops, discontinue administration and take appropriate measures to reduce serum potassium levels.
Use in the Elderly: Since elderly patients often have reduced physiological function and are likely to develop hepatic or cardiovascular dysfunction, the solution should be administered under careful supervision, such as reducing the dose by decreasing the infusion rate.
Use in Pregnancy & Lactation: The safety in pregnant women has not been established. Therefore, this product should be used in pregnant women and woman who may possibly be pregnant only if the expected therapeutic benefits outweigh any possible risk.